Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients. - Suppr | 超能文献

Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.

作者信息

Capone D, Gentile A, Vajro P, Stanziale P, Imperatore P, De Silva C, Pellegrino T, Basile V

机构信息

Department of Neurosciences, School of Medicine, Federico II University, Naples, Italy.

出版信息

J Chemother. 1998 Apr;10(2):176-8. doi: 10.1179/joc.1998.10.2.176.

DOI:10.1179/joc.1998.10.2.176

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.

J Chemother. 1998 Apr;10(2):176-8. doi: 10.1179/joc.1998.10.2.176.

2

Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.

Clin Biochem. 1998 Jul;31(5):309-16. doi: 10.1016/s0009-9120(98)00049-6.

3

Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.他克莫司在小儿肝移植患者中的群体药代动力学：移植后早期清除率。

Ther Drug Monit. 2011 Dec;33(6):663-72. doi: 10.1097/FTD.0b013e31823415cc.

4

Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.肝移植和肾移植中环孢素转换为他克莫司的情况。

Transplant Proc. 1996 Dec;28(6):3178-9.

5

Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center.肾移植中基于他克莫司的免疫抑制：日本单一中心的78例经验

Transplant Proc. 2002 Aug;34(5):1666. doi: 10.1016/s0041-1345(02)02972-x.

6

Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.估算儿科肾移植患者他克莫司个体暴露量的有限采样策略。

Ther Drug Monit. 2011 Dec;33(6):681-7. doi: 10.1097/FTD.0b013e318235d067.

7

Therapeutic drug monitoring of tacrolimus early after liver transplantation.肝移植术后早期他克莫司的治疗药物监测

Transplant Proc. 2002 Aug;34(5):1538-9. doi: 10.1016/s0041-1345(02)03010-5.

8

Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.肾移植受者中他克莫司每日剂量、谷浓度及相对清除率的临床影响因素

Transplant Proc. 2000 Nov;32(7):1689-92. doi: 10.1016/s0041-1345(00)01413-5.

9

Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants.全血中FK506浓度与肝肾移植排斥反应及毒性的关系。

J Biopharm Stat. 1996 Nov;6(4):411-24. doi: 10.1080/10543409608835153.

10

Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.肝移植患者转换为缓释他克莫司后的疗效表明，在特定队列中可能会有良好的结果。

Liver Transpl. 2015 Jan;21(1):29-37. doi: 10.1002/lt.24022.

引用本文的文献

1

Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.他克莫司在儿科和成年患者中的比较临床药代动力学。

Clin Pharmacokinet. 2001;40(4):283-95. doi: 10.2165/00003088-200140040-00004.